Repeat Expansions Analyzed
Our whole genome platform detects the characterized repeats listed below.
All of the listed repeats are analyzed by the following comprehensive analyses:
- Genomic Unity® 2.0
- Genomic Unity® Lightning 2.0 Genome Analysis – Standard
- Genomic Unity® Whole Genome Analysis
- Genomic Unity® Exome Plus Analysis
- Genomic Unity® Exome Analysis.
Some of the listed repeats are analyzed by our Neurology Analyses and/or Other Targeted Analyses, Genomic Unity® Lightning 2.0 Genome Analysis – NICU, and/or IriSight® Comprehensive Analysis – Prenatal tests. The relevant tests are noted in the following table. Follow the gene links for detailed information about reporting ranges.
Genomic Unity® 2.0, Genomic Unity® Lightning 2.0 Genome Analysis – Standard, and Genomic Unity® Lightning 2.0 Genome Analysis – NICU analyze additional repeats not available in other tests. The additional repeats are listed in a second, separate table.
Gene(s) | Repeat | Disorder | Additional Analyses That Include This STR |
CCG | Fragile XE syndrome | Genomic Unity® Epilepsy Analysis | Genomic Unity® X-Linked Intellectual Disability Plus Analysis | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal | |
CAG | Spinal and bulbar muscular atrophy | ||
GCN | X-linked Intellectual developmental disorder 29 and Partington syndrome | Genomic Unity® Epilepsy Analysis | Genomic Unity® Lightning 2.0 Analyses | |
CAG | Dentatorubral-pallidoluysian atrophy (DRPLA) | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Lightning 2.0 Analyses | |
ATXN1** § | CAG | Spinocerebellar ataxia 1 (SCA1) | |
ATTCT | Spinocerebellar ataxia 10 (SCA10) | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Renal Disorders Analysis | Genomic Unity® Lightning 2.0 Analyses | |
ATXN2 § | CAG | Spinocerebellar ataxia 2 (SCA2) | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Lightning 2.0 Analyses |
ATXN3 § | CAG | Spinocerebellar ataxia 3 (SCA3) | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Lightning 2.0 Analyses |
ATXN7 § | CAG | Spinocerebellar ataxia 7 (SCA7) | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Retinal Disorders Analysis | Genomic Unity® Lightning 2.0 Analyses |
ATXN80S § | CTG | Spinocerebellar ataxia 8 (SCA8) | |
C9orf72** § | GGGGCC | Frontotemporal dementia and/or amyotrophic lateral sclerosis (FTD ALS1) | |
CACNA1A** | CAG | Spinocerebellar ataxia 6 (SCA6) | |
CNBP § | CCTG | Myotonic dystrophy type II | Genomic Unity® Cardiomyopathy and Arrhythmia Analysis | Genomic Unity® Neuromuscular Disorders Analysis | Genomic Unity® Lightning 2.0 Analyses |
CCCCGCCCCGCG | Progressive myoclonic epilepsy, type 1A | Genomic Unity® Epilepsy Analysis | Genomic Unity® Lightning 2.0 Analyses | |
DIP2B § | CGG | FRA12A fragile site | Genomic Unity® Epilepsy Analysis | Genomic Unity® Lightning 2.0 Analyses |
DMPK § | CTG | Myotonic dystrophy type I | Genomic Unity® Cardiomyopathy and Arrhythmia Analysis | Genomic Unity® Neuromuscular Disorders Analysis | Genomic Unity® X-Linked Disability Plus Analysis | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal |
CGG | FMR1 disorders | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Epilepsy Analysis | Genomic Unity® X-Linked Intellectual Disability Plus Analysis | Genomic Unity® Genome-wide CNV and FMR1 Analysis | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal | |
GCN | Blepharophimosis, ptosis, and epicanthus inversus syndrome type II (BPES II) | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal | |
GAA | Friedreich’s ataxia | Genomic Unity® Cardiomyopathy and Arrhythmia Analysis | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Lightning 2.0 Analyses | |
GIPC1 § | GGC | Oculopharyngodistal myopathy 2 (OPDM2) | Genomic Unity® Neuromuscular Disorders Analysis | Genomic Unity® Neuropathies Analysis | Genomic Unity® Lightning 2.0 Analyses |
GCA | Global developmental delay, progressive ataxia, and elevated glutamine (GDPAG) | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Comprehensive Ataxia Analysis | Genomic Unity® Ataxia Repeat Expansion Analysis | Genomic Unity® Epilepsy Analysis | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal | |
CAG | Huntington disease | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Lightning 2.0 Analyses | |
CTG | Huntington disease-like 2 syndrome | ||
LRP12 § | CGG | Oculopharyngodistal myopathy 1 (OPDM1) | |
NOP56** § | GGCCTG | Spinocerebellar ataxia 36 (SCA36) | |
GGC | NOTCH2NLC-related GGC repeat expansion disorders | Genomic Unity® Movement Disorders Analysis | Genomic Unity® Lightning 2.0 Analyses | |
PABPN1** § | GCN | Oculopharyngeal muscular dystrophy (OPMD) | |
GCN | Congenital central hypoventilation syndrome 1 with or without Hirschsprung disease | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal | |
PPP2R2B § | CAG | Spinocerebellar ataxia 12 (SCA12) | |
RFC1** | AAGGG and other pathogenic repeats | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) | |
GCN | X-linked SOX3 GCN repeat expansion disorders | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal | |
TBP § | CAG/CAA | Spinocerebellar ataxia 17 (SCA17) | |
TCF4** | CTG or CAG | Fuchs endothelial corneal dystrophy | See comprehensive analyses above |
GGCGCGGAGC | Hereditary distal motor neuropathy with myopathic features (HMNMYO) | Genomic Unity® Neuromuscular Disorders Analysis | Genomic Unity® Neuropathies Analysis | Genomic Unity® Lightning 2.0 Analyses | |
GGC | Spinocerebellar ataxia 4 (SCA4) | ||
GCN | Holoprosencephaly 5 | Genomic Unity® Lightning 2.0 Analyses | IriSight® Comprehensive Analysis - Prenatal |
*In targeted gene panels, ARX repeat expansions will be reported only in cases where the clinical symptoms of the patient include early-onset seizures.
**As the disorders are typically adult onset, repeat expansions in these genes are not reported in minors in comprehensive analyses.
§ As the gene-disease association is mediated exclusively by repeat expansions, only repeat expansions are reported for this gene.
Additional repeats analyzed by Genomic Unity® 2.0 and Genomic Unity® Lightning 2.0 Analyses
Gene(s) | Repeat | Disorder | 2.0 Analyses That Include This STR |
BEAN1** § | TGGAA | Spinocerebellar ataxia 31 (SCA31) | |
ATTTC | Spinocerebellar ataxia 37 (SCA37) | ||
GAA | Spinocerebellar ataxia 27B (SCA27B) | ||
HOXA13 (3 tracts) | GCN | Hand-foot-genital syndrome (HFGS) | |
GCC | Hereditary sensory and autonomic neuropathy type VIII (HSAN8) | ||
PRNP ** | 4-base octapeptide PHGGGWGQ | Prion disease | |
RILPL1 ** § | CGG | Oculopharyngodistal myopathy type 4 (OPDM4) | |
CAG followed by GCN | Cleidocranial dysplasia (CCD) | ||
SAMD12 § | TTTCA | Familial adult onset myoclonic epilepsy 1 |
**As the disorders are typically adult onset, repeat expansions in these genes are not reported in minors in comprehensive analyses.
§ As the gene-disease association is mediated exclusively by repeat expansions, only repeat expansions are reported for this gene.